December 3, 2021
Life Sciences
  • The FDA is preparing to accelerate the review of vaccines and drugs targeting the omicron variant in case they’re needed. According to people familiar with the matter, agency officials are meeting with drugmakers and establishing guidelines for research. Vaccine manufacturers would need about three months to develop and test any new shots, and would be expected to meet standards similar to those for booster doses. (Article here)